Resources for healthcare professionals

Philips invasive and noninvasive ventilators are not available for sale to individuals, and can only be sold to hospitals, home medical equipment providers (DME companies), long term care facilities, medical transport, and government organizations.

Philips offers a broad portfolio of respiratory and oxygen products that are available through a physician’s prescription. You can view our portfolio of sleep and respiratory products here.

Our most needed products right now include our patient vital-signs monitors and portable ventilators and medical consumables for non-invasive and invasive ventilation to treat a broad range of respiratory conditions.

Philips products and solutions to manage COVID-19 include:

• Critical care point-solutions to treat respiratory disease. These include patient monitoring solutions to monitor a patient’s vital signs and detect subtle changes, and ventilators and medical consumables for invasive, non-invasive and mixed-mode ventilation to treat a broad range of respiratory conditions.
• Diagnostic imaging systems and services, including CT, mobile diagnostic X-ray, and ultrasound to help diagnose respiratory conditions.
• Hospital telehealth solutions to centrally monitor and manage patients in the intensive care unit (Philips eICU program), and telehealth solutions to connect caregivers and patients at home.

You can learn more about our solutions to manage COVID-19 here.

Philips is working around the clock to ramp up production of hospital ventilators and other critical care products to help diagnose and treat patients with the novel coronavirus (COVID-19). As initially communicated in March, we are doubling our production of hospital ventilators in May and will achieve a four-fold increase by the third quarter of 2020.

Our efforts to increase production have included:

• Hiring additional manufacturing employees and shifting current employees to support increased demand immediately;
• Adding manufacturing lines and increasing the number of shifts to 24/7 shifts;
• Working closely with Philips’ suppliers to secure materials supply to feed the increased production at our manufacturing sites;
• Leveraging Philips’ innovation capabilities to re-purpose adjacent product ranges to address the increased demand;
• Engaging with third party contract manufacturers Jabil and Flex

Our latest statements can be found on the Philips News Center.

For additional training on using Philips equipment, we’ve developed tutorial videos that can be accessed via our Philips COVID-19 response website.

For technical support and product servicing, we strongly recommend that only trained service personnel who have knowledge and experience with our ventilators, and who have read and comply with the instructions in the service manual, should service Philips ventilators.

Philips maintains a Business Continuity Management System, which is aligned to, and certified against, the international standard for Business Continuity ISO 22301:2012. We are constantly reviewing precautionary measures based on WHO and national authority guidelines.

Despite the COVID-19 pandemic, Philips has been able to continue its business operations around the world. As expected, we are seeing decreased demand for our consumer product portfolio in the most affected regions, and increased demand for our professional healthcare portfolio.

Philips has a balanced manufacturing footprint across the globe, with manufacturing sites in North America, Latin America, Europe, and Asia, including several in China. In line with our business continuity system, we have implemented the relevant safety protocols in all our worldwide sites.